Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Equipment
Datasets
Search by expertise, name or affiliation
CCSJ137X2201 A First-in-Human, Two-Part (Open Label, and Randomized/Bouble Blind/Placebo Controlled), Single- and Repeat-Dose Study of CSJ137 in Erythropoietin-Treated Chronic Hemodialysis Patients with Functional Iron-Deficiency Anemia
Gallon, Lorenzo
(PD/PI)
Medicine, Nephrology Division
Project
:
Research project
Overview
Project Details
Status
Finished
Effective start/end date
10/9/17
→
3/15/20
Funding
Novartis Pharmaceuticals Corporation
(CCSJ137X2201)
View all
View less